420
Participants
Start Date
September 15, 2021
Primary Completion Date
November 1, 2024
Study Completion Date
November 1, 2024
Umbilical Cord-Derived Wharton's Jelly Mesenchymal Stem Cells (WJ-MSCs)
cGMP grade WJ-MSCs. 10\^7 WJ-MSCs will be delivered through the intracoronary route. WJ-MSCs will be infused at a rate of 2.5 ml/min across three portions.
Conventional Treatment
Beta-blocker, angiotensin-converting enzyme (ACE) inhibitor, aldosterone antagonist, aspirin, ticagrelor, statin, and glyceryl trinitrate plus cardiac rehabilitation.
Al-Zahra Heart Hospital, Shiraz University of Medical Sciences, Shiraz
Faghihi Hospital, Shiraz
Namazee Hospital, Shiraz
National Institute of Medical Research Development (NIMAD), Iran
UNKNOWN
Shiraz University of Medical Sciences
OTHER